chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10/26/2009 Severe other                   10/26 vomited x 2 weak 10/26/2009 Severe other                   10/26 PM cough, respiratory distress fever/chills 10/27/2009 Sever other                      10/27 Red rash, entire body fever12/10/2009  PCP records from 10/28-11/7/2009, patient with c/o's fever, rash , fatigue, cough, groin swelling and poor appetite. Tx'd with ABX initially then steroids when rash didn't clear.
Achiness in his left side of the neck under the ear; Headache; Nausea; Stomach pains; Sleepiness; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pains), SOMNOLENCE (Sleepiness), NECK PAIN (Achiness in his left side of the neck under the ear), NAUSEA (Nausea) and HEADACHE (Headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pains), SOMNOLENCE (Sleepiness) and NAUSEA (Nausea). On 11-Mar-2021, the patient experienced NECK PAIN (Achiness in his left side of the neck under the ear) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) on 07-Mar-2021 at an unspecified dose and frequency. On 07-Mar-2021, ABDOMINAL PAIN UPPER (Stomach pains), SOMNOLENCE (Sleepiness) and NAUSEA (Nausea) had resolved. At the time of the report, NECK PAIN (Achiness in his left side of the neck under the ear) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
patient received vaccine and was waiting her 15 minute monitoring period, pt developed a flushed hot sensation and fell to the floor, she was picked up by her boyfriend and placed in a chair, she took off her heavy sweatshirt and drank water and started to feel better.
Weak, dizzy, pain in the arm where shot was given, a red spot formed on the arm temp - 102.0.
Stiffness and soreness in both shoulders and hips. Preliminary diagnosis of polymyalgia rheumatica.
Pt developed a stomach, h/a, sore throat, & t102; Also developed backache & T102.4;
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with PROQUAD injection, intramuscularly lot # N029156, expiration date 16-APR-2019, intramuscularly, for prophylaxis (dose and frequency were not reported). No adverse event reported.
Ground Glass Nodule found in CT  scan and MRI that were done 3 months after vaccine for Intercostal Nerve pain. Ground Glass Nodule was followed up with regular physician.  Dr looked through previous scans and found that Nodule was NOT present before  vaccine.
Itching, redness, soreness at injection site, about half dollar size- 1 week post vaccination
Pt came today to report adverse reaction that she felt like due to vaccine administration. Pt had received Moderna booster dose on 11/30/21. She said two days after the vaccination, she had tremors and sensory feeling in her vaccinated arm and then went away. She said it feels like at different spots, she has wierd sensations at diff times. It occurs occassionaly and predominently in vaccinated arm and sometimes in other arm. She said it has felt improved but did not go away completely. She was able do her routine work. She contacted md and md said to let pharmacy know. I suggested to use warm/cold compress at injection site. She was ok and just wanted to report the side effect that she thought could have occured due to vaccine.
Brain fog; Dizzy; Body aches; Headaches; Nausea; Chills; This is a spontaneous report received from a contactable consumer (patient herself). A 31-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: unknown) via an unspecified route of administration on 25Mar2021 at 01:00 PM as a single dose in the left arm for COVID-19 immunization in Public Health Clinic/Veterans Administration facility. Medical history included Diabetes, high blood pressure, severe asthma/type e asthma and Known allergies included Sulfa and shellfish. Patient was not pregnant at time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications in two weeks included mepolizumab (NUCALA), lisinopril, metformin, salbutamol (ALBUTEROL), breo and insu. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 01:00 PM, the patient experienced headaches, nausea, dizzy, brain fog, chills and body aches. The patient did not receive any treatment for the events. The outcome of the events headaches, nausea, dizzy, brain fog, chills and body aches were not recovered.  Information about the Lot/batch number has been requested.
Pt developed flu like symptoms about 2 hours post vax, along with chest pains and sore joints. Pain was sharp in chest. Ultram was used to control pain and symptoms. Symptoms are still occurring now, not all symptoms at one time, they can alternate or occur all at once.
NERVE PAINS THROUGHOUT THE BODY; DEHYDRATED; NOT BEING ABLE TO MOVE TO GET A DRINK; LIMBS WERE TOO STIFF AND STUCK TO SIDES; SEIZING UP AND SHAKING REAL BAD FOR  5 TO 10 MIN; FEVER SO BAD; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced nerve pains throughout the body, dehydrated, not being able to move to get a drink, limbs were too stiff and stuck to sides, seizing up and shaking real bad for 5 to 10 min, and fever so bad. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever so bad, nerve pains throughout the body, dehydrated, not being able to move to get a drink, limbs were too stiff and stuck to sides and seizing up and shaking real bad for 5 to 10 min was not reported. This report was non-serious.
HOARSENESS HIVES WEAKNESS AND SHAKINESS (SEVERE ON LEGS) 'FELT LIKE THROAT WERE DRY AND CLOSED WITH SUDDEN HOARSENESS BUT NO SHORT OF BREATH' 'FELT LIKE FALLING DOWN WITH SHAKINEE' *RECEIVED BENADRYL 50MG PO AT 10PM AFTER CONTACTED NURSING PRACTITIONER *REST WITH PLENTY OF FLUID PER RECOMMANDATION  *MONITOR FOR FURTHER SYMPTOMS AND DIRECTED TO GO TO ER IF SX NOT BETTER,  BUT SX GETS BETTER AM NEXT DAY 'STILL FEELS WEAK AND HAS MILD FLU SX SUCH AS ACHES, SORE THROAT, MILD SWEAT BUT NO FEVER
Patient presented to the Pharmacist on 11/25/19 with a swollen right hand in pain. She returned on 12/3/19 complaining of loss of arm strength in her right arm.
had not yet received the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 10th June 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. No further events were reported.  The reporter consented to follow up.
High fever and uncontrollable shaking for about two hours beginning at 3:30 in the morning, after administration of vaccine at 4:00 PM (approximately) the previous day. General lethargy, achiness, and headache for about two days afterward. Soreness at injection site for three days.
patient took the second dose of the vaccine >35 days after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient took the second dose of the vaccine >35 days after the first dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient took the second dose of the vaccine >35 days after the first dose). On 01-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient took the second dose of the vaccine >35 days after the first dose) had resolved.            No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Non-significant follow up. Patient initials updated.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) and PRODUCT STORAGE ERROR (Vaccine is given 30 days from storage and is expired) in a 67-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 013H21B) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy. On 30-Mar-2022 at 10:50 AM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 30-Mar-2022 at 10:50 AM,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine is given 30 days from storage and is expired). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) and PRODUCT STORAGE ERROR (Vaccine is given 30 days from storage and is expired) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) to be not related. No further causality assessment was provided for PRODUCT STORAGE ERROR (Vaccine is given 30 days from storage and is expired). Patient race was reported as Black. No concomitant medications were reported. The vial was initially stored in the refrigerator on 01-Mar-2022. Vial did not undergone to any temperature excursion. No treatment medications were reported.
Patient stated on 1/3/2022 in the evening, she got a bad headache. She had some relief with ibuprofen, but she was dehydrated, had chills, tired, vomiting and sore throat. Symptoms mostly resolved by 1/4/2022 at 5:10 pm. She reported she was able to drink fluids and keep them down.
Hypersensitivity reaction; 3x3 inch red circle around the injection site; sore; itchy rash at the injection site; mild itchy rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), VACCINATION SITE ERYTHEMA (3x3 inch red circle around the injection site) and VACCINATION SITE RASH (mild itchy rash at the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 016M20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu Vaccine in 2019. Past adverse reactions to the above products included Flu like symptoms with Flu Vaccine. Concurrent medical conditions included Wasp sting (Anaphylaxis) since 2020, Drug allergy (Nausea) since 2019, Drug allergy (Allergic reaction to mouth , gums swelling) since 2020, Anaphylaxis, Asthma, Hypersensitivity reaction, Hay fever and Urticaria. Concomitant products included ESTROGENS CONJUGATED (PREMARIN), SIMVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID), MULTIVITAMINS [VITAMINS NOS], VITAMIN C [ASCORBIC ACID], VITAMIN D [VITAMIN D NOS] and CALCIUM for an unknown indication.   On 11-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE RASH (mild itchy rash at the injection site). On 20-Jan-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction) and VACCINATION SITE ERYTHEMA (3x3 inch red circle around the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of 10 mg and ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]) at a dose of 20 mg for 10 days. On 26-Jan-2021, VACCINATION SITE ERYTHEMA (3x3 inch red circle around the injection site) and VACCINATION SITE RASH (mild itchy rash at the injection site) had resolved. On 30-Jan-2021, HYPERSENSITIVITY (Hypersensitivity reaction) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included triamcinolone Acetonide Cream (21-Jan-2021 To 31-Jan-2021)   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Updated patient info: address, race/ethnicity, and not pregnant. Updated info on 1st dose: arm, lot number, and time. Added conmeds, case became medically confirmed (patient sought medical care), patient got treatment from provider, and changed event outcome from 1st dose. On 18-Jun-2021: Follow up information was received on 18-Jun-2021 included patient medical history, allergic conditions, concomitant and treatment medication, events and outcome of the event.
I have changes to my period. The color of my period is brown and the flow is very light.
a red and warm spot around the injection site, with a size of a baseball ball; a red and warm spot around the injection site, with a size of a baseball ball; with a size of a baseball ball; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (a red and warm spot around the injection site, with a size of a baseball ball), INJECTION SITE WARMTH (a red and warm spot around the injection site, with a size of a baseball ball) and INJECTION SITE SWELLING (with a size of a baseball ball) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (a red and warm spot around the injection site, with a size of a baseball ball), INJECTION SITE WARMTH (a red and warm spot around the injection site, with a size of a baseball ball) and INJECTION SITE SWELLING (with a size of a baseball ball). At the time of the report, INJECTION SITE ERYTHEMA (a red and warm spot around the injection site, with a size of a baseball ball), INJECTION SITE WARMTH (a red and warm spot around the injection site, with a size of a baseball ball) and INJECTION SITE SWELLING (with a size of a baseball ball) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Body turned red. Itching was extremely bad and started at 3:30 on May 4th. Got prescribed Vistaril and a steroid. Back at the ER on the 6th blotchy and red streaks and itching EVERYWHERE. Changed steroid and gave me cream
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ lot # L008053 with exp. 30-NOV-2016, (dose and route were not provided). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a physician refers to a 16 year old patient of unknown gender. The patient's medical history and current conditions were not provided. On 31-MAR-2015, the patient was vaccinated with a dose of RECOMBIVAX HB lot # K018796, expiration date 24-OCT-2015, adult dose (1.0 ml) instead of a pediatric (0.5 ml) dose which was outside of the recommended per the RECOMBIVAX HB prescribing information. No adverse effects was reported. There was no product quality complaint (PQC) involved. Additional information has been requested.
august 1st went to the er due to a stiff and nerve pain in my neck.  after the visit they gave me Predezone. I wasnt getting any better, i went to ENT and I saw Dr. They gave me another round of Predeone steroid, they gave me a gabiltenton 100mg 3 times a day.  They also prescriped 1000mg of neproxen for inflamation.  I'm still using them for the pain, due to the it not going away.
Case number PHEH2012US009638 is an initial spontaneous report received from a pharmacist on 04 May 2012. This report refers to a patient whose age, gender, medical history, past drugs, current conditions and concomitant medications were not specified. It was reported that on an unspecified date, a patient was vaccinated only the MenCYW-135 liquid conjugate vaccine component of MENVEO (batch number: M11041) intramuscularly on to unspecified site and did not receive the MenA lyophilized conjugate vaccine component. No adverse event was reported.
Chills began last night at 6:45 pm and lasted until midnight. Legs were weak. Very lethargic. Feeling like this may occur again tonight. Felt fine all day today.
pain in the arm; swelling; aching all over; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), SWELLING (swelling) and PAIN (aching all over) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm), SWELLING (swelling) and PAIN (aching all over). At the time of the report, PAIN IN EXTREMITY (pain in the arm), SWELLING (swelling) and PAIN (aching all over) outcome was unknown.            This case was linked to MOD-2021-071345 (E2B Linked Report).; Sender's Comments:  MOD-2021-071345:1st dose case
feeling like flu; Pulsatile Tinnitus/throbbing in the right ear; ear infection/something wrong with her ear; sore arm; reaction was much worse; headache; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (feeling like flu), TINNITUS (Pulsatile Tinnitus/throbbing in the right ear), EAR INFECTION (ear infection/something wrong with her ear), PAIN IN EXTREMITY (sore arm) and CONDITION AGGRAVATED (reaction was much worse) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medication history was provided by the reporter.  Concomitant products included CALCIUM, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), CHONDROITIN SULFATE SODIUM, GLUCOSAMINE HYDROCHLORIDE, SODIUM (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE SODIUM;GLUCOSAMINE HYDROCHLORIDE;SODIUM]), PARACETAMOL (TYLENOL) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA (feeling like flu), TINNITUS (Pulsatile Tinnitus/throbbing in the right ear), EAR INFECTION (ear infection/something wrong with her ear), PAIN IN EXTREMITY (sore arm), CONDITION AGGRAVATED (reaction was much worse), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills). At the time of the report, INFLUENZA (feeling like flu), TINNITUS (Pulsatile Tinnitus/throbbing in the right ear), EAR INFECTION (ear infection/something wrong with her ear), PAIN IN EXTREMITY (sore arm), CONDITION AGGRAVATED (reaction was much worse), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            The treatment information was not provided.   This case was linked to MOD-2021-288121 (Patient Link).
Information has been received from a physician concerning a 14 year old female who between October 2006 and May 2007 the patient was vaccinated with her 3 doses of GARDASIL (lot# not reported). It was reported that after May 2007 the patient inadvertently received 2 additional doses of GARDASIL (lot# not provided) from a different physician's office. In April 2008 ("last week"), the patient developed headaches and leg pain. Patient outcome was not reported. The patient sought medical attention at the physician's office. Additional information has been requested.
7JUL92 recvd 1st dose of Engerix-B & 4 days later devel fever of 104, ear ache; dizziness; arthralgia; nausea; diarrhea; lymphadenopathy; swollen ankles; edema & referred pains;
tested positive for Covid-19; This is a spontaneous report from a contactable consumer (patient's wife). A 78-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EL8982), via an unspecified route of administration in right arm on 22Jan2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The consumer confirmed that the patient did not received other vaccines on the same day as the COVID vaccine. The consumer reported that she and the patient were scheduled for the second dose on 12Feb2021, 3 weeks later. On 27Jan2021, the patient underwent COVID-19 PCR test, which was positive on 28Jan2021. The consumer was also tested, and her test result was negative, but they were unsure if the patient got it from her because she had a minor exposure 14 days ago. The outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
2 days, post vax, broke out in red splotches on both legs and had flu-like symptoms prior to this (the day after the shot). Then developed excruciating leg, hip and knee pain. Saw a dermatologist on 9/29/00 and was on steroid therapy for 5 days which cleared up the rash but still had leg pain which is just now subsiding. Dx'd by PCP with viral syndrome and myalgias.
Immediate pain and muscle soreness at site of injection. Five days later the injection site itches, is bruised, and remains tender to touch.